ValueAct Capital Management, L.P. announced that it has sold 4.2 million shares of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE